Robert A. Kyle
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 18
- Glycosylation and Glycoproteins Research 5
- Protein Degradation and Inhibitors 3
- Hematology 26
- Multiple Myeloma Research and Treatments 24
- Co-authors
- M. A. Gertz (5 shared papers)Philip R. Greipp (7 shared papers)Morie A. Gertz (5 shared papers)S. Vincent Rajkumar (5 shared papers)Rafaël Fonseca (7 shared papers)Thomas E. Witzig (2 shared papers)Joan Bladé (1 shared paper)Angela Dispenzieri (5 shared papers)
- Journals
- Mayo Clinic Proceedings (5 papers)British Journal of Haematology (4 papers)Seminars in Oncology (3 papers)American Journal of Hematology (3 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesCubaItaly
In The Last Decade
Robert A. Kyle
44 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 90
- Hematology 1.1k
- Genetics 409
- Nephrology 225
- Oncology 586
- Molecular Biology 1.4k
Countries citing papers authored by Robert A. Kyle
This map shows the geographic impact of Robert A. Kyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Kyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Kyle more than expected).
Fields of papers citing papers by Robert A. Kyle
This network shows the impact of papers produced by Robert A. Kyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Kyle. The network helps show where Robert A. Kyle may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert A. Kyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic value of bone marrow angiogenesis in multiple myeloma. | 2000 | 270 |
| 2 | 1991 | 233 | |
| 3 | 2001 | 160 | |
| 4 | 1992 | 148 | |
| 5 | 2007 | 113 | |
| 6 | 1992 | 99 | |
| 7 | 1994 | 75 | |
| 8 | 1982 | 72 | |
| 9 | 1988 | 69 | |
| 10 | 1998 | 68 | |
| 11 | 1997 | 64 | |
| 12 | 1996 | 57 | |
| 13 | 1998 | 56 | |
| 14 | 2000 | 56 | |
| 15 | 1990 | 50 | |
| 16 | 1995 | 43 | |
| 17 | 1978 | 43 | |
| 18 | 1977 | 43 | |
| 19 | 1998 | 39 | |
| 20 | 1991 | 37 |
About Robert A. Kyle
Robert A. Kyle is a scholar working on Molecular Biology, Hematology, Oncology, Genetics and Surgery, having authored 45 papers that have together received 2.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (24 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers), Cancer Treatment and Pharmacology (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Glycosylation and Glycoproteins Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Pancreatitis Pathology and Treatment (4 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (409 citations), Nephrology (225 citations), Oncology (586 citations) and Molecular Biology (1.4k citations). Robert A. Kyle has collaborated with scholars based in United States, Cuba and Italy. Frequent co-authors include M. A. Gertz, Philip R. Greipp, Morie A. Gertz, S. Vincent Rajkumar, Rafaël Fonseca, Thomas E. Witzig, Joan Bladé, Angela Dispenzieri, John A. Lust and Brian Van Ness. Their work appears in journals such as Mayo Clinic Proceedings, British Journal of Haematology, Seminars in Oncology, American Journal of Hematology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.